%0 Journal Article
%T A review of non-classical MAPK family member, MAPK4: A pivotal player in cancer development and therapeutic intervention.
%A Yan Y
%A Dai T
%A Guo M
%A Zhao X
%A Chen C
%A Zhou Y
%A Qin M
%A Xu L
%A Zhao J
%J Int J Biol Macromol
%V 271
%N 0
%D 2024 Jun 25
%M 38801852
%F 8.025
%R 10.1016/j.ijbiomac.2024.132686
%X Mitogen-Activated Protein Kinases (MAPKs) are serine/threonine protein kinases that play a crucial role in transmitting extracellular signals to the intracellular environment, influencing a wide range of cellular processes including proliferation, differentiation, apoptosis, metabolic activities, immune function and stress response. MAPK4, a non-classical MAPK, is frequently overexpressed in various malignancies, including prostate, breast, cervix, thyroid, and gliomas. It orchestrates cell proliferation, migration, and apoptosis via the AKT/mTOR and/or PDK1 signaling pathways, thus facilitating tumor cell growth. Furthermore, MAPK4 expression is closely associated with the effectiveness of specific inhibitors like PI3K and PARP1, and also correlate with the survival rates of cancer patients. Increasing evidence highlights MAPK4's involvement in the tumor microenvironment, modulating immune response and inflammation-related diseases. This review comprehensively explores the structure, function, and oncogenic role of MAPK4, providing a deeper understanding of its activation and mechanisms of action in tumorigenesis, which might be helpful for the development of innovative therapeutic strategies for cancer management.